TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 4.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270,353 | +1.9% | 15,214 | +3.6% | 0.00% | 0.0% |
| Q2 2023 | $265,340 | +35.2% | 14,684 | -5.9% | 0.00% | 0.0% |
| Q1 2023 | $196,243 | -22.9% | 15,612 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $254,556 | +2.2% | 17,364 | +101.9% | 0.00% | 0.0% |
| Q2 2021 | $249,000 | -10.1% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $277,000 | -22.0% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $355,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |